Eversept Partners »

Celcuity shares owned by Eversept Partners

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 128k 104.62

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Encompass Health Corp (EHC)
Ensign (ENSG)
Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Travere Therapeutics (TVTX)
Caretrust Reit (CTRE)
Hca Holdings (HCA)
Vaxcyte (PCVX)

View all positions for Eversept Partners

Top funds holding Celcuity

Baker Bros. Advisors
venBio Select Advisor
Rtw Investments
Perceptive Advisors
BlackRock
Vanguard Capital Management
NEA Management Company
Soleus Capital Management
State Street Corporation
Bank of America Corporation
Deerfield Management Company
Morgan Stanley
Tang Capital Management
T. Rowe Price Associates
Toronto-Dominion Bank

View all funds holding Celcuity